Published in Biomed Res Int on September 08, 2013
Brain Angiotensin II AT1 receptors are involved in the acute and long-term amphetamine-induced neurocognitive alterations. Psychopharmacology (Berl) (2015) 0.76
Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) (2000) 5.19
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev (1992) 4.03
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev (1997) 3.80
Drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol (2004) 3.41
Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci (1997) 2.74
Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend (1998) 2.71
Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci (1989) 2.30
DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur J Neurosci (2005) 1.95
A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci (1999) 1.56
Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol. Neuropsychopharmacology (2010) 1.32
Induction of a salt appetite alters dendritic morphology in nucleus accumbens and sensitizes rats to amphetamine. J Neurosci (2002) 1.26
Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res (1988) 1.23
A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur J Neurosci (2001) 1.18
A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology (2006) 1.08
Effect of repetitive icv injections of ANG II on c-Fos and AT(1)-receptor expression in the rat brain. Am J Physiol Regul Integr Comp Physiol (2001) 1.06
Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regul Pept (2005) 1.04
Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment. Hypertension (2012) 1.02
Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res (2007) 1.01
Reciprocal cross-sensitization between amphetamine and salt appetite. Pharmacol Biochem Behav (2004) 0.93
A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress. Neuropsychopharmacology (2006) 0.93
Withdrawal duration differentially affects c-fos expression in the medial prefrontal cortex and discrete subregions of the nucleus accumbens in cocaine-sensitized rats. Neuroscience (2002) 0.90
Expression of amphetamine sensitization is associated with recruitment of a reactive neuronal population in the nucleus accumbens core. Psychopharmacology (Berl) (2008) 0.89
Induction and expression of salt appetite: effects on Fos expression in nucleus accumbens. Behav Brain Res (2006) 0.88
Compartment-specific changes in striatal neuronal activity during expression of amphetamine sensitization are the result of drug hypersensitivity. Eur J Neurosci (2002) 0.87
Sodium appetite and Fos activation in serotonergic neurons. Am J Physiol Regul Integr Comp Physiol (2002) 0.87
The brain pattern of c-fos induction by two doses of amphetamine suggests different brain processing pathways and minor contribution of behavioural traits. Neuroscience (2010) 0.86
Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo. Br J Pharmacol (1996) 0.84
Brain angiotensin II, an important stress hormone: regulatory sites and therapeutic opportunities. Ann N Y Acad Sci (2004) 0.84
Changes in angiotensin II receptors in dopamine-rich regions of the mouse brain with age and ethanol consumption. Brain Res (1999) 0.83
Stimulating effect of angiotensin II on the spontaneous release of newly synthetized [3H]dopamine in rat striatal slices. Neurosci Lett (1979) 0.82
[Angiotensin II and nigostriatal system (author's transl)]. J Physiol (Paris) (1981) 0.80
Distribution of Fos immunoreactivity in rat brain after sodium consumption induced by peritoneal dialysis. Am J Physiol (1999) 0.80
Behavioral cross-sensitization between DOCA-induced sodium appetite and cocaine-induced locomotor behavior. Pharmacol Biochem Behav (2011) 0.80
The AT₁ angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol. Synapse (2010) 0.79
Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility? Life Sci (2005) 0.78
Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: effects of angiotensin IV. Brain Res (2005) 0.78
Effect of angiotensin II on the Vogel conflict paradigm and on the content of dopamine and noradrenaline in rat brain. Acta Physiol Pharmacol Bulg (1990) 0.78
Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke (2002) 1.38
Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. Biochem J (2004) 1.25
A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology (2006) 1.08
Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regul Pept (2005) 1.04
Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Res (2004) 0.94
A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress. Neuropsychopharmacology (2006) 0.93
Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy. Endocrinology (2004) 0.88
Angiotensin II AT(1) and AT(2) receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription. Endocrinology (2003) 0.85
Allopregnanolone increase in striatal N-methyl-D-aspartic acid evoked [3H]dopamine release is estrogen and progesterone dependent. Cell Mol Neurobiol (2002) 0.83
Angiotensin II AT1 receptor blockade prolongs the lifespan of spontaneously hypertensive rats and reduces stress-induced release of catecholamines, glucocorticoids, and vasopressin. Ann N Y Acad Sci (2004) 0.82
Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy. FASEB J (2012) 0.82
Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats. Pharmacol Rep (2012) 0.82
Stress-induced sensitization to cocaine: actin cytoskeleton remodeling within mesocorticolimbic nuclei. Eur J Neurosci (2012) 0.81
The AT₁ angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol. Synapse (2010) 0.79
Substance abuse disorders. Handb Clin Neurol (2012) 0.78
Stress and angiotensin II: novel therapeutic opportunities. Curr Drug Targets CNS Neurol Disord (2003) 0.78
Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat. Behav Brain Res (2002) 0.77
Amphetamine triggers an increase in met-enkephalin simultaneously in brain areas and immune cells. J Neuroimmunol (2006) 0.77
Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat. Neuroendocrinology (2006) 0.77
Participation of catalase in voluntary ethanol consumption in perinatally low-level lead-exposed rats. Alcohol Clin Exp Res (2013) 0.76
Alpha and beta noradrenergic mediation of NMDA glutamatergic effects on lordosis behaviour and plasmatic LH concentrations in the primed female rat. J Neural Transm (Vienna) (2009) 0.76
Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats. Neuroendocrinology (2004) 0.75
Intra-amygdaloid microinjection of neuropeptide glutamic acid-isoleucine induces anxiety-like behavior. Neuroreport (2011) 0.75